Aurobindo Pharma Ltd.

BSE: 524804 | NSE: AUROPHARMA |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE406A01037 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Aurobindo Phar Aurobindo Pharma Ltd. | BSE 1168.90 -43.40 (-3.58%) | NSE 1172.10 -35.60 (-2.95%) | Trade | Add

BSE Live

Feb 01, 16:01

1168.90 -43.40 (-3.58%)

Volume

AVERAGE VOLUME

5-Day

171,636

10-Day

90,925

30-Day

50,727

25,858

Prev. Close

1212.30
Open Price

1215.00

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)

NSE Live

Feb 01, 15:57

1172.10 -35.60 (-2.95%)

Volume

AVERAGE VOLUME

5-Day

2,097,435

10-Day

1,394,344

30-Day

1,062,552

744,670

Prev. Close

1207.70
Open Price

1208.00

Bid Price (Qty.)
1172.10 (1535)
Offer Price (Qty.)
0.00 (0)

Financials

Print/Copy to Excel : Go

Profit & Loss account of Aurobindo Pharma (in Rs. Cr.)	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
	12 mths	12 mths	12 mths	12 mths	12 mths
INCOME
Revenue From Operations [Gross]	10,788.09	10,542.21	12,607.54	11,250.07	15,622.18
Less: Excise/Sevice Tax/Other Levies	0.00	0.00	0.00	0.00	0.00
Revenue From Operations [Net]	10,788.09	10,542.21	12,607.54	11,250.07	15,622.18
Total Operating Revenues	10,933.30	10,645.64	12,792.28	11,287.14	15,823.68
Other Income	328.12	616.06	433.76	670.99	589.86
Total Revenue	11,261.42	11,261.70	13,226.04	11,958.13	16,413.54
EXPENSES
Cost Of Materials Consumed	5,610.21	5,761.08	7,247.69	5,783.93	7,215.74
Purchase Of Stock-In Trade	65.13	203.40	89.23	16.81	26.09
Operating And Direct Expenses	0.00	0.00	0.00	0.00	0.00
Changes In Inventories Of FG,WIP And Stock-In Trade	-67.66	-116.23	-466.00	45.51	2.99
Employee Benefit Expenses	1,063.07	980.56	1,641.88	1,600.04	1,735.42
Finance Costs	230.04	182.60	114.98	16.94	28.68
Depreciation And Amortisation Expenses	297.20	254.58	435.35	415.26	488.00
Other Expenses	1,704.98	1,592.79	2,548.56	2,367.45	2,723.61
Total Expenses	8,902.97	8,858.78	11,611.69	10,245.94	12,220.53
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	2,358.45	2,402.92	1,614.35	1,712.19	4,193.01
Exceptional Items	0.00	0.00	0.00	-74.71	0.00
Profit/Loss Before Tax	2,358.45	2,402.92	1,614.35	1,637.48	4,193.01
Tax Expenses-Continued Operations
Current Tax	627.37	598.08	407.02	379.70	1,043.34
Less: MAT Credit Entitlement	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-15.71	-95.26	-23.08	-196.93	36.76
Tax For Earlier Years	0.00	0.00	0.00	0.00	0.00
Total Tax Expenses	611.66	502.82	383.94	182.77	1,080.10
Profit/Loss After Tax And Before ExtraOrdinary Items	1,746.79	1,900.10	1,230.41	1,454.71	3,112.91
Profit/Loss From Continuing Operations	1,746.79	1,900.10	1,230.41	1,454.71	3,112.91
Profit/Loss For The Period	1,746.79	1,954.14	1,230.41	1,454.71	3,112.91
OTHER ADDITIONAL INFORMATION
EARNINGS PER SHARE
Basic EPS (Rs.)	29.97	33.35	21.00	24.83	53.13
Diluted EPS (Rs.)	29.97	33.35	21.00	24.83	53.13
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS
Imported Raw Materials	0.00	0.00	0.00	0.00	0.00
Indigenous Raw Materials	0.00	0.00	0.00	0.00	0.00
STORES, SPARES AND LOOSE TOOLS
Imported Stores And Spares	0.00	0.00	0.00	0.00	0.00
Indigenous Stores And Spares	0.00	0.00	0.00	0.00	0.00
DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend	0.00	263.66	439.45	263.67	234.38
Tax On Dividend	0.00	0.00	0.00	0.00	0.00
Equity Dividend Rate (%)	0.00	450.00	300.00	900.00	400.00